Your browser doesn't support javascript.
loading
Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain.
Ahire, Chetan; Nyul-Toth, Adam; DelFavero, Jordan; Gulej, Rafal; Faakye, Janet A; Tarantini, Stefano; Kiss, Tamas; Kuan-Celarier, Anna; Balasubramanian, Priya; Ungvari, Anna; Tarantini, Amber; Nagaraja, Raghavendra; Yan, Feng; Tang, Qinggong; Mukli, Peter; Csipo, Tamas; Yabluchanskiy, Andriy; Campisi, Judith; Ungvari, Zoltan; Csiszar, Anna.
Afiliación
  • Ahire C; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Nyul-Toth A; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • DelFavero J; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Gulej R; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Faakye JA; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health and Translational Medicine, Semmelweis University, Budapest, Hungary.
  • Tarantini S; International Training Program in Geroscience, Institute of Biophysics, Biological Research Centre, ELKH, Szeged, Hungary.
  • Kiss T; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Kuan-Celarier A; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Balasubramanian P; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Ungvari A; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Tarantini A; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Nagaraja R; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Yan F; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Tang Q; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Mukli P; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health and Translational Medicine, Semmelweis University, Budapest, Hungary.
  • Csipo T; Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Yabluchanskiy A; The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Campisi J; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Ungvari Z; International Training Program in Geroscience, First Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Csiszar A; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Aging Cell ; 22(7): e13832, 2023 07.
Article en En | MEDLINE | ID: mdl-37243381

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Disfunción Cognitiva / Deterioro Cognitivo Relacionado con la Quimioterapia Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Aging Cell Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Disfunción Cognitiva / Deterioro Cognitivo Relacionado con la Quimioterapia Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Aging Cell Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos